Media headlines about Sabra Healthcare REIT (NASDAQ:SBRA) have been trending somewhat positive on Sunday, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Sabra Healthcare REIT earned a news impact score of 0.16 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 46.5187317164068 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:
Several research analysts recently commented on SBRA shares. Zacks Investment Research downgraded shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Thursday, June 8th. BidaskClub raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Tuesday, June 20th. Mizuho reaffirmed a “neutral” rating on shares of Sabra Healthcare REIT in a report on Wednesday, June 28th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $25.00 price objective (down from $28.00) on shares of Sabra Healthcare REIT in a report on Sunday, July 9th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a report on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company’s stock. Sabra Healthcare REIT has a consensus rating of “Hold” and an average target price of $25.00.
Sabra Healthcare REIT (NASDAQ:SBRA) traded up 0.47% during mid-day trading on Friday, reaching $23.46. 2,926,284 shares of the company’s stock traded hands. Sabra Healthcare REIT has a 12-month low of $19.30 and a 12-month high of $29.10. The company has a market cap of $3.75 billion, a P/E ratio of 19.71 and a beta of 0.89. The stock has a 50 day moving average of $22.35 and a 200 day moving average of $24.66.
The firm also recently declared a quarterly dividend, which was paid on Friday, August 18th. Shareholders of record on Wednesday, August 16th were paid a $0.3599 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 6.14%. The ex-dividend date of this dividend was Monday, August 14th. Sabra Healthcare REIT’s payout ratio is 122.03%.
COPYRIGHT VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Sabra Healthcare REIT (SBRA) Stock Price” was reported by Equities Focus and is the property of of Equities Focus. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.equitiesfocus.com/2017/09/17/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-sabra-healthcare-reit-sbra-stock-price.html.
Sabra Healthcare REIT Company Profile
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.